Nanomaterials for bone metastasis
X Hao, B Jiang, J Wu, D Xiang, Z Xiong, C Li… - Journal of Controlled …, 2024 - Elsevier
Bone metastasis, a prevalent occurrence in primary malignant tumors, is often associated
with a grim prognosis. The bone microenvironment comprises various coexisting cell types …
with a grim prognosis. The bone microenvironment comprises various coexisting cell types …
Bone-targeted biomaterials: Strategies and applications
X Ren, X Chen, Z Geng, J Su - Chemical Engineering Journal, 2022 - Elsevier
Bone diseases including osteoarthritis, osteoporosis, and bone tumors are becoming severe
threats to public health. Bone-targeted biomaterials-based strategies could improve …
threats to public health. Bone-targeted biomaterials-based strategies could improve …
[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting
KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …
Nanomedicines for the treatment of hematological malignancies
AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
Nanotechnology is a vigorous research area and one of its important applications is in
biomedical sciences. Among biomedical applications, targeted drug delivery is one of the …
biomedical sciences. Among biomedical applications, targeted drug delivery is one of the …
Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells
We present the synthesis of a silver nanoparticle (AgNP) based drug-delivery system that
achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) …
achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) …
Nanoparticles and their potential for application in bone
A Tautzenberger, A Kovtun… - International journal of …, 2012 - Taylor & Francis
Biomaterials are commonly applied in regenerative therapy and tissue engineering in bone,
and have been substantially refined in recent years. Thereby, research approaches focus …
and have been substantially refined in recent years. Thereby, research approaches focus …
Recent advances in the treatment of bone metastases and primary bone tumors: An up-to-date review
AE Bădilă, DM Rădulescu, AG Niculescu… - Cancers, 2021 - mdpi.com
Simple Summary Bone represents a common metastatic site for patients with advanced
cancers while also being associated with rare but challenging primary tumors. As the …
cancers while also being associated with rare but challenging primary tumors. As the …
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer
Delivery of therapeutic agents to bone is crucial in several diseases such as osteoporosis,
Paget's disease, myeloproliferative diseases, multiple myeloma as well as skeletal …
Paget's disease, myeloproliferative diseases, multiple myeloma as well as skeletal …
Targeting polymer therapeutics to bone
An aging population in the developing world has led to an increase in musculoskeletal
diseases such as osteoporosis and bone metastases. Left untreated many bone diseases …
diseases such as osteoporosis and bone metastases. Left untreated many bone diseases …